Skip to main content
FDA Updates
FDA Approves Split-Dosing Regimen for Daratumumab in Patients with Multiple Myeloma
Yvette Florio Lane
Read More
FDA Updates
February 8, 2019 - FDA Approvals, News & Updates
Yvette Florio Lane
Read More
FDA Updates
February 1, 2019 - FDA Approvals, News & Updates
Yvette Florio Lane
Read More
Breast Cancer
5 mg Tamoxifen as Effective as 20 mg Daily in Early Localized Breast Cancer
Phoebe Starr
Read More
Immunotherapy, Renal-Cell Carcinoma
Avelumab plus Axitinib Combination Improves Outcomes in Advanced Renal-Cell Carcinoma
Wayne Kuznar
Read More
FDA Updates
Government Shutdown Impacts FDA Drug Approvals
Yvette Florio Lane
Read More
Original Research
Comparing Outcomes in Patients with Recurrent or Refractory Ovarian Cancer Managed with 1 of 2 Versions of Pegylated Liposomal Doxorubicin at an Academic Medical Center
Lindsey B. Amerine, PharmD, MS, BCPS, Eric Shen, PharmD, Michelle Gardiner, PharmD, BCOP, CPP
Lindsey B. Amerine, PharmD, MS, BCPS; Eric Shen, PharmD; Michelle Gardiner, PharmD, BCOP, CPP
Read More
Original Research, Monoclonal Antibodies
Role of Pharmacist Intervention in the Safe Administration of Anti-CD20 Monoclonal Antibodies
Hayley Ann Hodgson, PharmD, Arpita S. Gandhi, PharmD, BCOP, Stephen Michael Clark, PharmD, BCOP
Hayley Ann Hodgson, PharmD; Arpita S. Gandhi, PharmD, BCOP; Stephen Michael Clark, PharmD, BCOP
Read More
Review Article
Review of PD-1–Induced Myositis and a Case of Pembrolizumab-Induced Myositis in a Patient with Metastatic Melanoma
Kirollos S. Hanna, PharmD, BCPS, BCOP
Kirollos S. Hanna, PharmD, BCPS, BCOP
Read More
Symptom Management Overview
Anthracycline-Induced Cardiotoxicity in Adults
Linda Blake, PharmD, PhD, BCPS, Alison Palumbo, PharmD, MPH, BCOP, Amber Diaz, PharmD, BCOP, Joseph Bubalo, PharmD, BCPS, BCOP
Linda Blake, PharmD, PhD, BCPS; Alison Palumbo, PharmD, MPH, BCOP; Amber Diaz, PharmD, BCOP; and Joseph Bubalo, PharmD, BCPS, BCOP
Read More
Page 153 of 196
Results 1521 - 1530 of 1954